ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Sleep science is rewriting the rules on rest, exposing myths about sleep cycles, alarms, and nutrition while offering a path ...

A good night’s sleep is just as vital as a balanced diet and regular exercise. Poor sleep affects mood, brain function, and ...

A burlesque boss accused of raping a woman in his Sydney apartment has been acquitted after arguing he suffered from an ...

Robert F. Kennedy Jr. will appear Thursday morning before the Senate health committee for a second confirmation hearing. Lawmakers will likely question him about his shifting beliefs on vaccines and ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...